Stock Exchange Electronic Trading Service (SETS) is London Stock Exchange’s flagship electronic order book, trading FTSE 100, FTSE 250, FTSE Small Cap Index constituents, Exchange Traded Funds (ETFs) and Exchange Traded Products (ETPs), plus other liquid AIM, Irish and London Standard-listed securities. London Stock Exchange also operates a version of SETS on a modified trading cycle that supports securitised derivatives.
Functionally rich with multiple order types, SETS is one of the most liquid electronic order books in Europe. It is this liquidity, underpinned by a rigorous rulebook and market supervision, and a wide and diverse set of participants, that creates opportunity to do business. Market participants can choose from three fully inter-operable competing clearers, ensuring pre- and post-trade anonymity and full counterparty risk protection.
Draper Esprit, a leading venture capital firm investing in and developing high growth digital technology businesses, today announces that it has moved its listings from London’s AIM and Dublin’s Euronext Growth Market to their respective main market partners. Its shares will today begin trading on the Premium Segment of London’s Main Market with a secondary listing on Euronext Dublin.
London Stock Exchange welcomes Zenova Group Plc to AIM in order to facilitate its plan to introduce its innovative cutting edge technologically driven products.
Zenova has developed a set of new fire safety and temperature management products that address the most pressing problems in this sector in a very efficient and cost effective way.
These comprise fire retardant pai
London, UK – 23 July 2021 – Rize UCITS ICAV (“Rize ETF”), Europe’s first specialist thematic ETF issuer, has today unveiled a brand new ETF targeting environmental sustainability. The Rize Environmental Impact 100 UCITS ETF (LIFE) is the first ETF of its kind in Europe, and is available to buy from today on London Stock Exchange trading under the tickers LIFE (USD) and LVNG (GBP). In addition t
London Stock Exchange today welcomes GENinCode plc (“GENinCode” or the “Company” with the LSE-AIM ticker “GENI”), the cardiovascular disease (“CVD”) risk assessment company focused on predictive genetics for the prevention of cardiovascular disease. The Company is incorporated in England and Wales with its UK headquarters in Oxford.
The Company has successfully raised £17 millio